Underweight: Trim 40-50% at $152; hard stop at $134.63; re-enter on breakout above $157.11 or retest confirmation with macro relief
Underweight with 40-50% trim threads the needle: large enough to materially reduce two-stacked-catalyst (Flight 14 + Q3 earnings within 30 days) exposure given 9+ bearish overlay signals, small enough to preserve 50-60% of benchmark-relative participation if the institutional floor defends or Starship Flight 14 produces upside surprise. The 8/14 SPCX binding reflection on operational inflection (+92% YoY Q2 revenue, GM 55.3%, OCF flip to +$2.42B) and institutional floor defense (Nvidia $21B 13F, Harvard $2.2B, Alphabet $94B) remain dispositive against full Sell. Five converging bearish factors at $152 (87.6x forward P/E on speculative EPS recovery, -$25.9B TTM FCF funded by $85.7B equity dilution, hostile technicals with 73% MACD collapse and Bollinger rejection at $156.60, 5% 10-year yield with 84% Polymarket Fed hike odds, and 51% Polymarket Starship underperformance probability) mandate action but not elimination. The trim itself provides asymmetry — capturing downside protection while preserving re-engagement optionality into the Sept 28 binary.
| Position | Action |
|---|---|
| Current position at $152 | Trim 40-50% of long exposure |
| Confirmed close below $145 on volume | Trim additional 25% |
| Residual position sizing | Worst-case 50% drawdown scenario with 1.5-2x ATR ($7.43) tolerance per Research Manager's framework |
SPCX's combination of 90%+ revenue growth, $100B cash, dominant market position, and asymmetric Starship catalyst creates a compelling asymmetric risk/reward that favors the bull over the next 30 days.
| Indicator | Value | Signal |
|---|---|---|
| close | 152.71 | neutral |
| 10_ema | 149.36 | bullish |
| 50_sma | 134.63 | bullish |
| macd | 4.22 | neutral |
| macd_histogram | +0.34 | bearish |
| rsi | 57.96 | neutral |
| bollinger_middle | 145.33 | neutral |
| bollinger_upper | 157.11 | bearish |
| atr | 7.43 | neutral |
Support: 145.33 · 134.63 | Resistance: 157.11
SPCX exhibits a classic momentum divergence pattern: price is recovering from the Jul 31 low of $108.37 and currently sits well above the 50 SMA (+13.4%), confirming the intermediate-term uptrend is intact. However, the MACD histogram's 73% compression over 7 sessions despite higher price action, combined with RSI failing to confirm the recent high and upper Bollinger Band rejection at $157.11, signals short-term buyers are losing conviction. Volume today (335.2M) was ~3× the typical 50–80M range, a distribution warning flag requiring follow-through confirmation. The report recommends holding existing longs with a trailing stop at $145.28 (close minus 1× ATR) and awaiting either a clean breakout above $157.11 on volume ≥150M or a successful pullback retest of the $145–$149 zone before initiating new positions.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful retest of $145-149 zone with volume confirmation AND macro relief (10-year <4.75%)
Then: Re-engage long position
↩ rebuts: “Bear valuation concerns”
· concedes: 87.6x forward P/E is expensive by conventional metrics; Starship Flight 14 faces real delay risk (Sept 22 → Sept 28); Higher-for-longer rates could compress multiples in the near term; Any broad market correction would drag SPCX despite strong fundamentals
SPCX is burning $25.9B annually in free cash flow while funding operations through massive equity dilution, with technical momentum in decay, valuation at 87.6x forward earnings, and a binary Starship catalyst that Polymarket prices at 51% probability of disappointment.
· concedes: Q1 2026 operating income was -$1.95B — not just preferred stock conversion accounting (bull overstated Q1 loss explanation); Falcon 9, Starlink, and NASA contracts form a viable base case business; Revenue did grow 92% YoY; The base case (non-Starship) business is generating growing revenue; A successful Starship Flight 14 could produce meaningful upside to $170 zone
→ vs conservative: Long-term thesis being 'intact' doesn't protect against 49% drawdowns between here and there; capital preservation matters more than thesis-calling
→ vs conservative: NASA contracts and fortress balance sheet don't change that valuation, momentum, and macro are stacked against the next 6-10% of price action
→ vs neutral: Waiting for confirmation in a high-volatility name costs 15-20% of position value by the time MACD rolls below zero and 50-SMA at $134.63 is tested
→ vs conservative: Polymarket consensus pricing disappointment means the 'disappointment trade tends to overshoot'; don't be long when bad news is already priced in
Market Cap
$2.013 trillion
52-Week Range
$104.83 – $225.64
50-Day Average
$134.62
200-Day Average
$142.64
Current Price
~$152.81
Forward PE
87.61x
Price/Book
15.82x
EPS (TTM)
-$1.10
Forward EPS
$1.74
TTM Revenue
$23.04 billion
TTM Gross Profit
$11.95 billion
TTM EBITDA
$5.90 billion
TTM Net Income
-$8.89 billion
TTM CapEx
> $30 billion
Q1 2025 Revenue
$4.067 billion
Q2 2025 Revenue
$4.071 billion
Q1 2026 Revenue
$4.694 billion
Q2 2026 Revenue
$7.814 billion
Q1 2026 YoY Revenue Growth
+15.4%
Q2 2026 YoY Revenue Growth
+91.9%
Q2 2026 Gross Profit
$4.32 billion
Q2 2026 Gross Margin
55.3%
Q1 2026 Gross Margin
49.1%
Q2 2025 Gross Margin
43.9%
Q1 2025 Gross Margin
51.8%
Q2 2026 EBITDA
$2.96 billion
Q1 2026 EBITDA
-$1.16 billion
Q2 2026 Operating Income
-$141 million
Q1 2026 Operating Income
-$1.95 billion
Q2 2026 Net Income
-$541 million
Q1 2026 Net Income
-$4.28 billion
Q2 2026 R&D Expense
$3.55 billion
Q1 2026 R&D Expense
$3.51 billion
Q2 2025 R&D Expense
$1.96 billion
Q1 2025 R&D Expense
$1.56 billion
Cash & Equivalents
$100.0 billion
Q1 2026 Cash & Equivalents
$23.7 billion
Total Assets
$192.8 billion
Total Debt
$39.7 billion
Stockholders' Equity
$127.2 billion
Working Capital
$86.9 billion
Q1 2026 Working Capital
$5.3 billion
Current Ratio
5.11x
Debt/Equity
31.21x
Additional Paid-In Capital (Q2 2026)
$167.3 billion
Additional Paid-In Capital (Q1 2026)
$74.1 billion
Tangible Book Value (Q2 2026)
$113.2 billion
Tangible Book Value (Q1 2026)
$20.1 billion
Q2 2026 Operating Cash Flow
$2.42 billion
Q2 2026 CapEx
$19.24 billion
Q1 2026 CapEx
$10.11 billion
Q2 2026 Free Cash Flow
-$16.82 billion
Q2 2026 Financing Activities
$93.17 billion
Equity Issuance
$85.7 billion
Strengths
Concerns
SPCX operates as a mega-cap aerospace and defense company with a $2.013 trillion market capitalization, generating $23.04B in trailing twelve-month revenue with exceptional 92% year-over-year growth in Q2 2026. The company maintains strong gross margins of 52% TTM and a massive $100B cash position, but remains unprofitable with a TTM net loss of $8.89B and negative free cash flow of $25.9B due to heavy R&D spending ($3.55B in Q2 2026 alone) and capital expenditures supporting Starship development and Starlink expansion. The valuation appears stretched at 87.6x forward earnings, suggesting the market is pricing in significant future growth and profitability assumptions.
Macro: The dominant macro theme is a decisive hawkish repricing: the 10-year Treasury yield is hovering near 5%, and Polymarket shows 84% implied probability of additional Fed rate hikes in 2026 with the "exactly 2 hikes" scenario at 60% (up 21.5pp week-over-week). The probability of a Fed rate cut by December 2026 has collapsed to just 3%. US recession is priced at only 8%, consistent with a "soft-landing with additional hikes" consensus baseline. The previous summer narrative of imminent Fed cuts and cheap money fueling growth-asset enthusiasm has evaporated entirely. Geopolitical tail risks persist (JPMorgan abandoned forecasting an Iran war endgame; Trump told reporters \"anything could happen\"), keeping oil and defense/aerospace names bid as a marginal positive for SPCX. FRED direct data was unavailable, but qualitative signals from news sources and prediction markets are unambiguous in their hawkish signal.